[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 5-14

Título :	Optimizing limbic selective d2/d3 receptor occupancy by risperidone: a [123i]-epidepride spet study
Tipo de documento:	texto impreso
Autores:	Rodrigo A. Bressan, Autor ; Kjell Erlandsson, Autor ; Hugh M. Jones, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 5-14
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Sistema Límbico, Sistema límbico, Pirrolidinas, Receptores de dopamina D2, Risperidona, Esquizofrenia.
Resumen:	Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects. Although risperidone is an atypical antipsychotic with high affinity for D2 receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms.
Link:	./index.php?lvl=notice_display&id=31038

[artículo] Optimizing limbic selective d2/d3 receptor occupancy by risperidone: a [123i]-epidepride spet study [texto impreso] / Rodrigo A. Bressan, Autor ; Kjell Erlandsson, Autor ; Hugh M. Jones, Autor . - 2023 . - pp. 5-14.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 5-14

Palabras clave:	Antipsicóticos, Sistema Límbico, Sistema límbico, Pirrolidinas, Receptores de dopamina D2, Risperidona, Esquizofrenia.
Resumen:	Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects. Although risperidone is an atypical antipsychotic with high affinity for D2 receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms.
Link:	./index.php?lvl=notice_display&id=31038